Stocktoria
WATERS CORP /DE/ WAT
NYSE · stock · Laboratory Analytical Instruments · website · IPO 1995-11-17
WATERS CORP /DE/ financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.2B | $3.0B | $3.0B | $3.0B | $2.8B | $2.4B | $2.4B | $2.4B | $2.3B | $2.2B |
| R&D expense | $195.7M | $183.0M | $174.9M | $176.2M | $168.4M | $140.8M | $143.0M | $143.4M | $132.6M | $125.2M |
| SG&A expense | $830.4M | $690.1M | $736.0M | $658.0M | $627.0M | $553.7M | $534.8M | $536.9M | $544.4M | $512.3M |
| Operating income | $802.6M | $826.4M | $817.7M | $873.4M | $821.7M | $645.5M | $708.5M | $739.8M | $662.2M | $625.0M |
| Interest expense | $69.5M | $89.7M | $98.9M | $48.8M | $44.9M | $49.1M | $48.7M | $48.6M | $56.8M | $44.9M |
| Income tax | $112.2M | $117.0M | $94.0M | $130.1M | $113.3M | $89.3M | $86.0M | $88.4M | $620.8M | $78.6M |
| Net income | $642.6M | $637.8M | $642.2M | $707.8M | — | — | — | — | — | — |
| EPS (diluted) | $10.76 | $10.71 | $10.84 | $11.73 | $11.17 | $8.36 | $8.69 | $7.65 | $0.25 | $6.41 |
| Operating cash flow | $652.6M | $762.1M | $602.8M | $611.7M | $747.3M | $790.5M | $643.1M | $604.4M | $697.6M | $642.9M |
| Cash & equivalents | $588.0M | $325.4M | $395.1M | $480.5M | $501.2M | $436.7M | $335.7M | $796.3M | $642.3M | $505.6M |
| Inventory | $572.0M | $477.3M | $516.2M | $455.7M | $356.1M | $304.3M | $320.6M | $291.6M | $270.3M | $262.7M |
| Total assets | $5.1B | $4.6B | $4.6B | $3.3B | $3.1B | $2.8B | $2.6B | $3.7B | $5.3B | $4.7B |
| Total liabilities | $2.5B | $2.7B | $3.5B | $2.8B | $2.7B | $2.6B | $2.8B | $2.2B | $3.1B | $2.4B |
| Shareholders' equity | $2.6B | $1.8B | $1.2B | $504.5M | $367.6M | $232.1M | -$216.3M | $1.6B | $2.2B | $2.3B |
Growth · year-over-year · Revenue CAGR 4.3%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +7.0% | +0.1% | -0.5% | +6.7% | +17.8% | -1.7% | -0.6% | +4.8% | +6.5% | +6.1% |
| Net income growth | +0.8% | -0.7% | -9.3% | — | — | — | — | — | — | — |
| EPS growth | +0.5% | -1.2% | -7.6% | +5.0% | +33.6% | -3.8% | +13.6% | +2960.0% | -96.1% | +13.5% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.